COMMUNIQUÉS West-GlobeNewswire

Leads Biolabs' PD-L1/4-1BB Bispecific Antibody IND Application for Combination Therapy in Metastatic Colorectal Cancer Approved, Further Strengthening Gastrointestinal Oncology Franchise
03/08/2026
NANJING, China, Aug. 02, 2026 (GLOBE NEWSWIRE) -- Nanjing Leads Biolabs Co., Ltd. (“Leads Biolabs” or the “Company,” Stock Code: 9887.HK) today announced that the Center for Drug Evaluation (CDE) of the National Medical [...]
Ascentage Pharma Appoints Dr. Faiçal Miyara as Chief Business Officer and Jim Ziegler as Chief Commercial Officer
03/08/2026
Appointments put dedicated leadership behind two separate priorities: building Ascentage Pharma’s own commercial organization in the United States, and expanding its global business development program ROCKVILLE, Md., [...]
We The Billions Launches Personalized Cognitive Care Focused on How Each Brain Works
02/08/2026
Speech-language pathologist Sanna Darwish says understanding how a brain works, not just what diagnosis it may carry, could reshape the future of cognitive care. Clarksville, MD, Aug. 01, 2026 (GLOBE NEWSWIRE) -- We The [...]
NOX Peptides Releases Updated Quality and Testing Information for Wolverine Stack Research Blend
02/08/2026
Toronto, Canada, Aug. 02, 2026 (GLOBE NEWSWIRE) -- NOX Peptides has released updated quality assurance and testing information for the Wolverine Stack research blend, providing additional transparency regarding product [...]
Appointment of new CFO
01/08/2026
ANNOUNCEMENT NO. 310 1 August 2026 Appointment of new CFO The board of ChemoMetec has appointed Phillip Massie Price as the new CFO with effect from 3 August 2026. Phillip Massie Price joins ChemoMetec from a position [...]
Precipio Announces Q2-2026 Shareholder Update Call
31/07/2026
Conference Call will be held on August 17th, 2026, at 5:00 PM EDT NEW HAVEN, Conn., July 31, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , will be hosting its Q2-2026 [...]
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
31/07/2026
VANCOUVER, BC and BOSTON, MA, July 31, 2026 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and [...]
FDA approves Pluvicto for PSMA+ metastatic hormone-sensitive prostate cancer (mHSPC), advancing potential new standard of care across metastatic disease
31/07/2026
Pluvicto now approved across PSMA+ metastatic prostate cancer, nearly doubling eligible patient population PSMAddition updated results show Pluvicto reduced risk of progression or death by 33% in combination with [...]
Entera Bio to Participate in the Canaccord Genuity 46th Annual Growth Conference
31/07/2026
TEL AVIV, July 31, 2026 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) (“Entera” or the “Company”), a leader in the development of oral peptides, today announced that the Company’s Chief Executive Officer, Miranda [...]
Cannabix Technologies Annual General Meeting Results
31/07/2026
VANCOUVER, British Columbia, July 31, 2026 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) (Frankfurt: 8CT) (the “Company” or “Cannabix”) announces the results of its annual general meeting of [...]
XORTX Announces Director Resignation
31/07/2026
CALGARY, Alberta, July 31, 2026 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company focused on developing [...]
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
31/07/2026
MALVERN, Pa., July 31, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a leader in interventional mental health that combines its NeuroStar® TMS technology with direct patient care through the Greenbrook [...]
Profusa Announces Signing of Option Agreement for the Acquisition of a Commercial Stage Diagnostics Company, G3 Vision Labs
31/07/2026
BERKELEY, Calif., July 31, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (Nasdaq: PFSA), a digital health company pioneering next-generation biosensing technologies, announces the signing of an Option Agreement (the “Agreement [...]
Turkish Airlines Sports Club Women’s Volleyball Team Completes Pre-Season Health Checks at Medicana
31/07/2026
The renewed healthcare sponsorship brings together one of Turkiye’s leading volleyball teams and Medicana Health Group’s multidisciplinary expertise in athlete health and preventive care ISTANBUL, July 31, 2026 (GLOBE [...]
Moleculin Announces Pricing of $9.3 Million Public Offering
31/07/2026
HOUSTON, July 31, 2026 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc. , (Nasdaq: MBRX) (“Moleculin” or the “Company”), today announced the pricing of a best-efforts public offering of an aggregate of 12,376,667 shares of [...]
Human Appeal USA Announces "The Biggest Comedy Show" 2026 Tour: A 25-City Nationwide Event Where Every Laugh Gives Back to Global Humanitarian Relief
31/07/2026
MISSION VIEJO, Calif., July 31, 2026 (GLOBE NEWSWIRE) -- Human Appeal USA, a humanitarian nonprofit, announced the Biggest Comedy Show 2026 tour, which will launch this fall across 25 U.S. cities. The tour unites [...]
EUROAPI_Mise à disposition du Rapport Financier Semestriel 2026
31/07/2026
Communiqué de presse Paris, le 31 juillet 2026 Mise à disposition du Rapport financier semestriel 2026 EUROAPI a mis en ligne ce jour ses Etats Financiers semestriels consolidés condensés 2026 pour la période close le [...]
EUROAPI_Availability of 2026 Half-year results financial report
31/07/2026
Press Release Paris, 31 July 2026 Availability of 2026 Half-Year Financial Report EUROAPI posted today its 2026 condensed Half Year Consolidated Financial Statements for the six months ended June 30, 2026. This document [...]
Italfarmaco Announces Managed Entry Agreement in Georgia for Givinostat as Treatment for Patients with Duchenne Muscular Dystrophy
31/07/2026
MILAN, Italy, July 31, 2026 – Italfarmaco S.p.A. today announced a managed entry agreement with the Georgian Ministry of Health for givinostat (Duvyzat ® ) as a treatment for patients with Duchenne muscular dystrophy ( [...]

Pages